[Use of pyrimidinol-carbamate in the therapy of peripheral obliterative arteriopathies]. [electronic resource]

By:

Tardito, E

Contributor(s):

Trezzi, M
Papackaralambus, D

Producer: 19710324Description: 692-705 p. digitalISSN:

0026-4725

Subject(s):

Adult
Aged
Angiography
Arm -- blood supply
Arteriosclerosis Obliterans -- drug therapy
Carbamates -- therapeutic use
Humans

In: Minerva cardioangiologica vol. 18

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Browse results Close

Back to results

61 Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease.
by Milsom, J W
62 Phase I trial of weekly docetaxel and daily temozolomide in patients with metastatic disease.
by Tamaskar, I
63 A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinoma.
by Perez-Zincer, F
64 Interferon-alpha and survival in renal cell cancer.
by Fossa, S
65 Cisplatin, carboplatin, and cyclophosphamide combination chemotherapy in advanced-stage ovarian carcinoma: an Eastern Cooperative Oncology Group pilot study.
by Grem, J
66 Cervical cancer screening by simple visual inspection after acetic acid.
by Belinson, J L
67 Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma.
by Witte, R S
68 A 2 weeks on and 1 week off schedule of sunitinib is associated with decreased toxicity in metastatic renal cell carcinoma.
by Najjar, Y G
69 Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus recombinant human granulocyte colony-stimulating factor in advanced urothelial carcinoma: an Eastern Cooperative Oncology Group trial.
by Loehrer, P J
70 Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer.
by Rajagopalan, K
71 The colposcopic impression. Is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear?
by Pretorius, R G
72 A phase II trial of melphalan or thioguanine in the treatment of patients with advanced renal cell cancer.
by Witte, R S
73 Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12.
by Ulchaker, J
74 Temsirolimus in VEGF-refractory metastatic renal cell carcinoma.
by MacKenzie, M J
75 The impact of interleukin-2 on survival in renal cancer: a multivariate analysis.
by Jones, M
76 Randomized phase II evaluation of carboplatin and CHIP in advanced transitional cell carcinoma of the urothelium. The Eastern Cooperative Oncology Group.
by Trump, D L
77 Clinical outcome of stereotactic radiosurgery for central nervous system metastases from renal cell carcinoma.
by Seastone, D J
78 GM-CSF safety and effects in the management of advanced/refractory multiple myeloma patients: a phase I trial.
by Hussein, M A
79 Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib.
by Tamaskar, I
80 Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma.
by Olencki, T

[Use of pyrimidinol-carbamate in the therapy of peripheral obliterative arteriopathies].

APA

Tardito E., Trezzi M. & Papackaralambus D. (19710324). [Use of pyrimidinol-carbamate in the therapy of peripheral obliterative arteriopathies]. : Minerva cardioangiologica.

Chicago

Tardito E, Trezzi M and Papackaralambus D. 19710324. [Use of pyrimidinol-carbamate in the therapy of peripheral obliterative arteriopathies]. : Minerva cardioangiologica.

Harvard

Tardito E., Trezzi M. and Papackaralambus D. (19710324). [Use of pyrimidinol-carbamate in the therapy of peripheral obliterative arteriopathies]. : Minerva cardioangiologica.

MLA

Tardito E, Trezzi M and Papackaralambus D. [Use of pyrimidinol-carbamate in the therapy of peripheral obliterative arteriopathies]. : Minerva cardioangiologica. 19710324.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC